Can agent-based simulation be used as a tool to support polypharmacy prescribing practice?
Chalk, D; Manzi, S; Britten, N; et al.Kluettgens, B; Magura, R; Valderas, J
Date: 30 May 2017
Journal
BMJ Simulation and Technology Enhanced Learning
Publisher
BMJ Publishing Group
Publisher DOI
Abstract
Objective We sought to develop a simulation modelling method to help better understand the complex interplay of factors that lead to people with type 2 diabetes and asthma not taking all of their medication as prescribed when faced with multiple medications (polypharmacy).
Research design and methods In collaboration with polypharmacy ...
Objective We sought to develop a simulation modelling method to help better understand the complex interplay of factors that lead to people with type 2 diabetes and asthma not taking all of their medication as prescribed when faced with multiple medications (polypharmacy).
Research design and methods In collaboration with polypharmacy patients, general practitioners, pharmacists and polypharmacy researchers, we developed a map of factors that directly and indirectly affect somebody’s decision to take their medication as prescribed when faced with multiple type 2 diabetes and asthma medications. We then translated these behavioural influences into logical rules using data from the literature and developed a proof-of-concept agent-based simulation model that captures the medicine-taking behaviours of those with type 2 diabetes and asthma taking multiple medications and which predicts both the clinical effectiveness and rates of adherence for different combinations of medications.
Conclusions The model we have developed could be used as a prescription support tool or a way of estimating medicine-taking behaviour in cost-effectiveness analyses.
Institute of Health Research
Collections of Former Colleges
Item views 0
Full item downloads 0